Clinical Trials Browser

Phase 2 × Suspended × Thoracic × Clear all

NCT05960773 2026-04-17

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

Phase 2 Suspended

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT05903092 2026-04-07

MOZART

Phase 2 Suspended

Small Cell Lung Carcinoma

NCT06385262 2026-03-06

TOP 2301: Neoadjuvant Chemo for NSCLC

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

NCT05337735 2025-10-09

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

Phase 2 Suspended

EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT02356991 2019-11-04

A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

NCT01723306 2016-06-14

Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas

Phase 2 Suspended

GastrointestinalThoracic

Lung Neoplasms, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT01356303 2016-05-13

TAXIS01

Phase 2 Suspended

Lung Neoplasms

NCT02470065 2016-01-22

REMNANT

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

NCT00986284 2015-12-22

Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

NCT01088620 2013-03-14

Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung